Latest 13D/G Reports

Since Nov 12, 2025

Company Symbol Filer Shares owned Ownership %
Prime Medicine, Inc. PRME GV 2019, L.P. 16.6M 12.3%
BLUE WATER ACQUISITION C-A BLUW BARCLAYS PLC 2.05M 7.88%
BLUE ACQUISITION CORP-CL A BACC BARCLAYS PLC 1.63M 7.81%
Jumia Technologies AG JMIA Fund 1 Investments, LLC 19.2M 7.83%
CARTESIAN GROWTH CORP I-CL A CGCT BARCLAYS PLC 2.1M 7.59%
TERAWULF INC. WULF JANE STREET GROUP, LLC 20.7M 5.1%
CRANE HARBOR ACQU CORP - A CHAC BARCLAYS PLC 1.72M 7.58%
Sotera Health Co SHC WARBURG PINCUS & CO. 73M 25.7%
Corbus Pharmaceuticals Holdings, Inc. CRBP CITADEL ADVISORS LLC 981K 5.3%
BEYOND MEAT, INC. BYND JANE STREET GROUP, LLC 22.7M 5.7%
FRANKLIN STREET PROPERTIES CORP /MA/ FSP Odle Jonathan Bennett 3M 2.9%
Elastic N.V. ESTC Banon Shay 6.45M 6.1%
Dutch Bros Inc. BROS Boersma Travis 50.7M 28.9%
TEXAS VENTURES ACQUISITION-A TVA BARCLAYS PLC 1.71M 7.58%
NMP ACQUISITION CORP - A NMP BARCLAYS PLC 905K 7.45%
Morningstar, Inc. MORN Mansueto Daniel 3.42M 8.2%
NOVAVAX, INC. NVAX SHAH CAPITAL MANAGEMENT 13.5M 8.3%
Zepp Health Corporation ZEPP INTEGRATED CORE STRATEGIES (US) LLC 6.63M 5.8%
Cosan S.A. CSAN Queluz Holdings Ltd. 822M 20.7%
StubHub Holdings, Inc. STUB WestCap Management, LLC 31.7M 9.89%
SHOULDER INNOVATIONS, INC. SI cultivate(MD) Holdings, LLC 1.36M 6.7%
Pegasystems Inc. PEGA TREFLER ALAN 79.2M 46%
Morningstar, Inc. MORN Mansueto Joseph D 15M 36.2%
THAYER VENTURES ACQUIS CL A TVAI BARCLAYS PLC 1.52M 7.41%
Monte Rosa Therapeutics, Inc. GLUE Versant Venture Capital VI, L.P. 3.33M 5.1%
LEE ENTERPRISES, Inc LEE GAMCO INVESTORS, INC. ET AL 0 0%
UiPath, Inc. PATH Dines Daniel 106M 19.9%
Myriad Genetics, Inc. MYGN INTEGRATED CORE STRATEGIES (US) LLC 4.75M 5.1%
Wesdome Gold Mines Ltd WDOFF VAN ECK ASSOCIATES CORP 14.6M 9.7%
SEABRIDGE GOLD INC SA VAN ECK ASSOCIATES CORP 8.29M 8.24%
Cheer Holding, Inc. CHR BIGGER CAPITAL FUND L P 10M 8.83%
ROYAL GOLD INC RGLD VAN ECK ASSOCIATES CORP 5.02M 7.64%
DUNE ACQUISITION CORP II IPOD BARCLAYS PLC 1.06M 7.32%
New Gold Inc. /FI NGD VAN ECK ASSOCIATES CORP 76.7M 9.69%
LIVE OAK ACQUISITION CORP-A LOKV BARCLAYS PLC 1.64M 7.13%
Inflection Point Acquisition Corp. IV BACQ Hudson Bay Capital Management LP 1.24M 4.89%
ZENTALIS PHARMACEUTICALS INC ZNTL BARCLAYS PLC 3.84M 5.32%
AXIOM INTELLIGENCE-CL A AXIN BARCLAYS PLC 1.09M 5.27%
Scorpius Holdings, Inc. SCPX 3i, LP 6.79M 9.9%
CORE SCIENTIFIC INC CORZ BARCLAYS PLC 16.2M 5.27%
DarioHealth Corp. DRIO Tasso Partners, LLC 676K 9.99%
Nasus Pharma Ltd. NSRX Megiddo Dalia 1.89M 20.9%
LITHIUM AMERICAS CORP. LAC VAN ECK ASSOCIATES CORP 14.5M 5.99%
MediaAlpha, Inc. MAX INSIGNIA CAPITAL PARTNERS GP, L.L.C. 0 0%
Klarna Group plc KLAR JACOBSSON KARL ANDERS VICTOR 24.1M 6.4%
Rollins, Inc. ROL ROLLINS GARY W 160M 33.3%
VINE HILL CAPITAL INVESTMENT CORP VCIC GOLDMAN SACHS GROUP INC 1.65M 7.5%
Nano Nuclear Energy Inc. NNE VAN ECK ASSOCIATES CORP 2.6M 6.25%
Grifols SA GRFS BRANDES INVESTMENT PARTNERS, LP 29.1M 19.6%
Lithium Argentina AG LAR VAN ECK ASSOCIATES CORP 9.63M 5.93%
IAMGOLD CORP IAG VAN ECK ASSOCIATES CORP 53M 9.22%
MoonLake Immunotherapeutics MLTX Deep Track Capital, LP 4.61M 6.46%
BEASLEY BROADCAST GROUP INC BBGI GAMCO INVESTORS, INC. ET AL 0 0%
Arqit Quantum Inc. ARQQ Heritage Assets SCSp. 9.27M 41.8%
HARMONY GOLD MINING CO LTD HMY VAN ECK ASSOCIATES CORP 40.8M 6.41%
Inspira Technologies OXY B.H.N. Ltd. IINN Hayon Joe Ronen 3.29M 9.7%
RITHM ACQUISITION CORP RAC GOLDMAN SACHS GROUP INC 1.16M 4.8%
FORTUNA MINING CORP. FSM VAN ECK ASSOCIATES CORP 29.8M 9.7%
FG MERGER II CORP FGMC BARCLAYS PLC 540K 5.24%
FIRST MAJESTIC SILVER CORP AG VAN ECK ASSOCIATES CORP 43.2M 8.84%
WEN ACQUISITION CORP-A WENN BARCLAYS PLC 1.57M 5.24%
Equinox Gold Corp. EQX VAN ECK ASSOCIATES CORP 97M 12.77%
Vital Farms Inc VITL WASATCH ADVISORS LP 2.36M 5.3%
enCore Energy Corp. EU VAN ECK ASSOCIATES CORP 16M 8.55%
ELDORADO GOLD CORP /FI EGO VAN ECK ASSOCIATES CORP 16.6M 8.16%
DENISON MINES CORP. DNN VAN ECK ASSOCIATES CORP 63.2M 7.04%
INTELLIA THERAPEUTICS, INC. NTLA GOLDMAN SACHS GROUP INC 5.5M 5.1%
Coeur Mining, Inc. CDE VAN ECK ASSOCIATES CORP 66.2M 10.3%
B2GOLD CORP BTG VAN ECK ASSOCIATES CORP 116M 8.77%
Arlo Technologies Inc ARLO WASATCH ADVISORS LP 5.51M 5.3%
Berkshire Hathaway Inc. BRKA BUFFETT WARREN E 196K 37.7%
CAPITAL BANCORP, INC. CBNK Levitt Randall James 968K 5.8%
ALAMOS GOLD INC AGI VAN ECK ASSOCIATES CORP 46.8M 11.12%
Willow Lane Acquisition Corp. WLAC Hudson Bay Capital Management LP 0 0%
Anterix Inc. ATEX DG Capital Management, LLC 745K 4%
PROTHENA CORP PUBLIC LTD CO PRTA Fennell Todd W. 4.5M 8.4%
INDIVIOR PLC INDV GOLDMAN SACHS GROUP INC 6.53M 5.2%
ScanSource Inc SCSC WASATCH ADVISORS LP 1.14M 5.2%
CUMULUS MEDIA INC-CL A CMLS BARCLAYS PLC 897K 5.23%
PROTHENA CORP PUBLIC LTD CO PRTA SCULLY WILLIAM P 5.28M 9.8%
SHENANDOAH TELECOMMUNICATION SHEN BARCLAYS PLC 2.86M 5.2%
FIFTH ERA ACQUISITION CORP I FERA GOLDMAN SACHS GROUP INC 1.05M 4.4%
CAL REDWOOD ACQUISIT-CL A CRAQ BARCLAYS PLC 1.21M 5.11%
GRAHAM CORP GHM BRANDES INVESTMENT PARTNERS, LP 1.37M 12.5%
Drugs Made In America Acquisition Corp. DMAA Hudson Bay Capital Management LP 1.55M 4.62%
VINE HILL CAPITAL-CLASS A VCIC BARCLAYS PLC 1.1M 5.01%
ENERGIZER HOLDINGS, INC. ENR GOLDMAN SACHS GROUP INC 3.57M 5.2%
Boxlight Corporation BOXL Kazazian Asset Management, LLC 157K 2.9%
nCino Inc NCNO WASATCH ADVISORS LP 4.96M 4.3%
CLASSOVER HOLDINGS, INC. KIDZ GOLDMAN SACHS GROUP INC 1.02M 5.3%
MYRIAD GENETICS INC MYGN BARCLAYS PLC 3.94M 4.23%
Ontrak, Inc. OTRKQ Hudson Bay Capital Management LP 398K 4.99%
IRONWOOD PHARMACEUTICALS INC IRWD BARCLAYS PLC 3.17M 1.95%
IB ACQUISITION CORP IBAC BARCLAYS PLC 459K 8%
SPRINGWORKS THERAPEUTICS, INC. SWTX GOLDMAN SACHS GROUP INC 132 0%
StealthGas Inc. GASS Glendon Capital Management LP 4.84M 13.52%
Esperion Therapeutics Inc ESPR WASATCH ADVISORS LP 7.06M 3.5%
Globant S.A. GLOB BRANDES INVESTMENT PARTNERS, LP 2.31M 5.2%
SIZZLE ACQUISITION CORP-CL A SZZL BARCLAYS PLC 1.63M 6.9%
MacroGenics Inc MGNX WASATCH ADVISORS LP 1.95M 3.1%